Lifevantage Corp (LFVN) stock
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 16/3023% below fair value
$4.97−0.07 (-1.39%)
Close on Nov 13, 2026Market cap $62.26MP/E 23.7Yield 3.72%
Lifevantage cash
Cash and short-term investments held at the end of each period.
Lifevantage's cash was $13.73M at Sep 30, 2026. For fiscal 2026 it was $14.92M, down 26.1% from the year before. Over ten years it grew 6.6% a year on average. The highest annual figure on record is $26.30M in fiscal 2013.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $14.92M | -26.1% |
| FY2025 | Jun 30, 2025 | $20.20M | +19.6% |
| FY2024 | Jun 30, 2024 | $16.89M | -21.8% |
| FY2023 | Jun 30, 2023 | $21.61M | +7.0% |
| FY2022 | Jun 30, 2022 | $20.19M | -12.9% |
| FY2021 | Jun 30, 2021 | $23.17M | +4.7% |
| FY2020 | Jun 30, 2020 | $22.14M | +17.6% |
| FY2019 | Jun 30, 2019 | $18.82M | +13.0% |
| FY2018 | Jun 30, 2018 | $16.65M | +45.3% |
| FY2017 | Jun 30, 2017 | $11.46M | +45.4% |
| FY2016 | Jun 30, 2016 | $7.88M | -43.3% |
| FY2015 | Jun 30, 2015 | $13.91M | -31.8% |
| FY2014 | Jun 30, 2014 | $20.39M | -22.5% |
| FY2013 | Jun 30, 2013 | $26.30M | +6.7% |
| FY2012 | Jun 30, 2012 | $24.65M | +266.7% |
| FY2011 | Jun 30, 2011 | $6.72M | +310.3% |
| FY2010 | Jun 30, 2010 | $1.64M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $13.73M | +4.9% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $14.92M | -26.1% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $12.48M | -44.4% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $10.18M | -52.9% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $13.09M | -10.3% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $20.20M | +19.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $22.47M | +29.3% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $21.60M | +24.6% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $14.60M | -20.7% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $16.89M | -21.8% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $17.38M | -11.0% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $17.33M | -0.2% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $18.41M | +4.5% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $21.61M | +7.0% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $19.53M | +9.7% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $17.37M | -13.9% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $17.62M | -11.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $20.19M | -12.9% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $17.80M | -6.1% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $20.17M | +2.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $19.93M | +11.0% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $23.17M | +4.7% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $18.96M | +40.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $19.73M | +36.2% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $17.96M | +38.1% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $22.14M | +17.6% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $13.46M | -15.4% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $14.48M | -23.8% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $13.01M | -24.0% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $18.82M | +13.0% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $15.91M | +14.1% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $18.99M | +48.4% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $17.12M | +39.3% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $16.65M | +45.3% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $13.95M | +51.6% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $12.79M | +39.0% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $12.29M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $11.46M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $9.20M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $9.20M | – |
See a number that looks wrong?